16th Annual Congress on Bioavailability & Bioequivalence

Topics

• Bioequivalence
• Bioavailability
• Regulatory Requirements for Bioequivalence
• Factors Affecting Bioavailability
• Study Designs
• Bioequivalence Protocols: In vivo/ In vitro studies
• Significance of BA/BE Studies
• BA/BE studies of Biologics and Biosimilars
• Clinical Pharmacology and Therapeutics
• Clinical Trails
• Drug Metabolism
• Challenges in Drug Design and Development
• Pharmacology- PK & PD approach
• Biosimilars
• Clinical Research Vs Clinical Trails
• Pharmaceutical Formulations
• Recent approaches to Biosimilars
• BCS & IVIVC Based Bio waivers
• Drug Safety